Brand name on outer carton alone is insufficient for patent medicament classification; goods fall under other medicaments.

A mark appearing only on the outer carton was treated as a brand name because it indicated trade connection, but that was insufficient to make the export goods patent or proprietary medicaments where the capsules and blisters did not bear the mark. Under Chapter Note 2(ii) of Chapter 30, the brand name must appear on the goods themselves or on their container; on that basis, the goods fell under Heading 3003.20 rather than Heading 3003.10. The penalty under the Central Excise Rules, 1944 was also considered excessive in the circumstances and was substantially reduced.

---

---

Issues: (i) whether the export goods bearing the mark "SOL" on the cartons were classifiable as patent or proprietary medicaments under Heading 3003.10 or as other medicaments under Heading 3003.20; (ii) whether the penalty imposed under the Central Excise Rules, 1944 required reduction.

Issue (i): whether the export goods bearing the mark "SOL" on the cartons were classifiable as patent or proprietary medicaments under Heading 3003.10 or as other medicaments under Heading 3003.20.

Analysis: The mark "SOL" as used on the carton was held to function as a brand name because it indicated a trade connection between the goods and their manufacturer. However, the material did not show that the capsules or the blisters containing them bore that brand name. Under Chapter Note 2(ii) of Chapter 30, the goods must bear the brand name on the goods themselves or on their container. Since the brand name appeared only on the cartons and not on the capsules or blisters, the export goods did not satisfy the definition of patent or proprietary medicaments.

Conclusion: The export goods were classifiable under Heading 3003.20 and not under Heading 3003.10.

Issue (ii): whether the penalty imposed under the Central Excise Rules, 1944 required reduction.

Analysis: The dispute concerned classification, and the quantum of penalty imposed was found to be excessive in the circumstances. The Tribunal considered the nature of the controversy and found the penalty harsh.

Conclusion: The penalty was reduced from Rs. 15 lakhs to Rs. 1,00,000/-.

Final Conclusion: The classification adopted by the Revenue was upheld, the duty demand was affirmed for the relevant period, and the penalty was substantially reduced.

Ratio Decidendi: For a medicament to qualify as a patent or proprietary medicament under Chapter Note 2(ii), the brand name must be borne on the goods themselves or on their container; a mark appearing only on the outer carton is insufficient where the goods or blisters do not bear that mark.

---